D-0427-2017 Class III Terminated

Recalled by Pharm D Solutions, LLC — Houston, TX

FDA drug recall D-0427-2017 was initiated by Pharm D Solutions, LLC on Oct 12, 2016 and is designated Class III. Reason for recall: Labeling; Error on Declared Strength; product description incorrectly states HCG 7500 units instead of 5000 units. The primary panel is correct The recall status is terminated (terminated May 11, 2017). Affected quantity: 112 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 18, 2017
Initiation Date
Oct 12, 2016
Termination Date
May 11, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
112 bottles

Product description

HCG-Vitamin B12 5000 IU-8 mg in 10 mL vial, Rx only, For Sub-Q & IM Injection, Pharm D Solutions, Loop West Houston, TX --- NDA 69699-1723-20

Reason for recall

Labeling; Error on Declared Strength; product description incorrectly states HCG 7500 units instead of 5000 units. The primary panel is correct

Distribution pattern

AZ and WA

Code information

Lots: 07272016:03 Expiration Date: 01/23/2017 and 09142016:88 Expiration Date: 03/07/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0427-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0427-2017. Report a data issue: hello@regdatalab.com.